Stable Antibody Formulation

Patent No. EP4249512 (titled "Stable Antibody Formulation") was filed by Regeneron Pharmaceuticals on Mar 23, 2018. The application was issued on Jul 23, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANApr 23, 2026HANCOCK

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4249512

REGENERON PHARMACEUTICALS
Application Number
EP23177973A
Filing Date
Mar 23, 2018
Status
Granted And Under Opposition
Jun 20, 2025
Publication Date
Jul 23, 2025